Valuation: GC Corp.

Market Cap 431B 315M 277M 261M 238M 446M 30.23B 449M 3.13B 1.21B 15.39B 1.18B 1.16B 50.07B P/E 2024
33.4x
P/E 2025 -10.4x
Enterprise Value 1,825B 1.33B 1.17B 1.11B 1.01B 1.89B 128B 1.9B 13.27B 5.14B 65.13B 5.01B 4.9B 212B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 -
1 day-0.84%
1 week-2.58%
Current month-5.88%
1 month-8.35%
3 months-7.63%
6 months-31.74%
Current year-40.70%
1 week 9,400
Extreme 9400
9,700
1 month 9,380
Extreme 9380
11,470
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
34,000
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 28/02/2010
Chief Executive Officer 72 24/03/2010
Director of Finance/CFO 53 -
Director TitleAgeSince
Chairman 72 16/12/2010
Director/Board Member 76 28/02/2009
Director/Board Member 52 28/02/2010
Date Insider Type Main position Quantity % Market Cap. Importance
25/04/25 Buy

Chief Executive Officer

1,334 0.0028%
25/04/25 Buy

Chief Executive Officer

3,191 0.0068%
25/04/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.84%-2.58%-42.44%-34.85% 316M
+2.68%+2.56%+59.32%+114.68% 1,026B
+0.56%+0.17%+53.19%+68.65% 649B
+0.02%+0.42%+20.51%+73.58% 468B
+0.06%+0.61%+39.82%+45.71% 352B
+1.16%+2.53%+21.60%+29.39% 271B
-0.24%-0.23%+10.62%+12.26% 256B
-0.01%+6.91%+45.42%+51.68% 220B
-1.11%-0.80%+31.69%+99.56% 188B
+0.30%-9.43%-31.91%-60.56% 170B
Average -0.01%+0.21%+20.78%+40.01% 359.94B
Weighted average by Cap. +0.12%+1.06%+38.35%+67.67%

Financials

2024 2025
Net sales 2,205B 1.61B 1.42B 1.34B 1.22B 2.28B 155B 2.3B 16.03B 6.21B 78.68B 6.05B 5.92B 256B 2,451B 1.79B 1.58B 1.48B 1.35B 2.53B 172B 2.55B 17.82B 6.9B 87.48B 6.72B 6.58B 285B
Net income 24.03B 17.55M 15.44M 14.55M 13.28M 24.83M 1.68B 25.02M 175M 67.67M 857M 65.89M 64.46M 2.79B -69.51B -50.78M -44.66M -42.1M -38.41M -71.84M -4.87B -72.4M -505M -196M -2.48B -191M -187M -8.07B
Net Debt 1,042B 761M 670M 631M 576M 1.08B 73.06B 1.09B 7.57B 2.93B 37.19B 2.86B 2.8B 121B 1,394B 1.02B 896M 844M 770M 1.44B 97.75B 1.45B 10.13B 3.93B 49.75B 3.82B 3.74B 162B
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
144
Date Price Change Volume
23/09/26 ₩9,440.00 -0.84% 31,614
22/09/26 ₩9,520.00 -1.04% 33,365
21/09/26 ₩9,620.00 +0.73% 40,239
18/09/26 ₩9,550.00 -1.44% 37,239
17/09/26 ₩9,690.00 +2.32% 71,271
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock